EFFICACY OF ATORVASTATIN IN REDUCING PROTEINURIA IN PATIENTS OF CHRONIC KIDNEY DISEASE

Objective: To determine the efficacy of atorvastatin in reducing proteinuria in patients of chronic kidney disease. Study Design: Quasi experimental study. Place and Duration of Study: Combined Military Hospital Multan, from Jan 2014 to Jun 2014. Material and Methods: Seventy patients of bo...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Rizwan Azam, Ejaz Ahmed, Asad Raza, Mahwish Rizwan, Ali Jamal, Syed Salman Ali
Formato: article
Lenguaje:EN
Publicado: Army Medical College Rawalpindi 2019
Materias:
R
Acceso en línea:https://doaj.org/article/e114ee44175f46adb5e160ccc7fb473d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e114ee44175f46adb5e160ccc7fb473d
record_format dspace
spelling oai:doaj.org-article:e114ee44175f46adb5e160ccc7fb473d2021-11-11T04:32:46ZEFFICACY OF ATORVASTATIN IN REDUCING PROTEINURIA IN PATIENTS OF CHRONIC KIDNEY DISEASE0030-96482411-8842https://doaj.org/article/e114ee44175f46adb5e160ccc7fb473d2019-08-01T00:00:00Zhttps://www.pafmj.org/index.php/PAFMJ/article/view/3206/2315https://doaj.org/toc/0030-9648https://doaj.org/toc/2411-8842Objective: To determine the efficacy of atorvastatin in reducing proteinuria in patients of chronic kidney disease. Study Design: Quasi experimental study. Place and Duration of Study: Combined Military Hospital Multan, from Jan 2014 to Jun 2014. Material and Methods: Seventy patients of both genders with documented chronic kidney disease (GFR <90>15ml/min) for at least 3 months duration were included by non-probability consecutive sampling. Age of the patients and reduction in proteinuria from the baseline after using atorvastatin was noted. The data were analyzed by using SPSS v 19. Descriptive statistics like mean ± SD, percentages and frequencies were calculated for age and efficacy of atorvastatin. The data collected for study was statistically analyzed using chi-square test. Results: The overall efficacy of atorvastatin was 31.43%. Twenty two out of 70 subjects had significant reduction in proteinuria i.e.>0.25 gm/24 hrs from baseline after statin use. A significant statistical association was not seen in the efficacy of atorvastatin between males and females, p-value being >0.05. Conclusion: A notable number of patients had improvement in their 24 hours proteinuria after the use of atorvastatin. Therefore atorvastatin use may be beneficial in all patients of chronic kidney disease as it will reduce progression of the disease and prevent rate of decline in renal functioning.Rizwan AzamEjaz AhmedAsad RazaMahwish RizwanAli JamalSyed Salman AliArmy Medical College Rawalpindiarticleatorvastatinchronic kidney diseaseefficacyMedicineRMedicine (General)R5-920ENPakistan Armed Forces Medical Journal, Vol 69, Iss 4, Pp 818-821 (2019)
institution DOAJ
collection DOAJ
language EN
topic atorvastatin
chronic kidney disease
efficacy
Medicine
R
Medicine (General)
R5-920
spellingShingle atorvastatin
chronic kidney disease
efficacy
Medicine
R
Medicine (General)
R5-920
Rizwan Azam
Ejaz Ahmed
Asad Raza
Mahwish Rizwan
Ali Jamal
Syed Salman Ali
EFFICACY OF ATORVASTATIN IN REDUCING PROTEINURIA IN PATIENTS OF CHRONIC KIDNEY DISEASE
description Objective: To determine the efficacy of atorvastatin in reducing proteinuria in patients of chronic kidney disease. Study Design: Quasi experimental study. Place and Duration of Study: Combined Military Hospital Multan, from Jan 2014 to Jun 2014. Material and Methods: Seventy patients of both genders with documented chronic kidney disease (GFR <90>15ml/min) for at least 3 months duration were included by non-probability consecutive sampling. Age of the patients and reduction in proteinuria from the baseline after using atorvastatin was noted. The data were analyzed by using SPSS v 19. Descriptive statistics like mean ± SD, percentages and frequencies were calculated for age and efficacy of atorvastatin. The data collected for study was statistically analyzed using chi-square test. Results: The overall efficacy of atorvastatin was 31.43%. Twenty two out of 70 subjects had significant reduction in proteinuria i.e.>0.25 gm/24 hrs from baseline after statin use. A significant statistical association was not seen in the efficacy of atorvastatin between males and females, p-value being >0.05. Conclusion: A notable number of patients had improvement in their 24 hours proteinuria after the use of atorvastatin. Therefore atorvastatin use may be beneficial in all patients of chronic kidney disease as it will reduce progression of the disease and prevent rate of decline in renal functioning.
format article
author Rizwan Azam
Ejaz Ahmed
Asad Raza
Mahwish Rizwan
Ali Jamal
Syed Salman Ali
author_facet Rizwan Azam
Ejaz Ahmed
Asad Raza
Mahwish Rizwan
Ali Jamal
Syed Salman Ali
author_sort Rizwan Azam
title EFFICACY OF ATORVASTATIN IN REDUCING PROTEINURIA IN PATIENTS OF CHRONIC KIDNEY DISEASE
title_short EFFICACY OF ATORVASTATIN IN REDUCING PROTEINURIA IN PATIENTS OF CHRONIC KIDNEY DISEASE
title_full EFFICACY OF ATORVASTATIN IN REDUCING PROTEINURIA IN PATIENTS OF CHRONIC KIDNEY DISEASE
title_fullStr EFFICACY OF ATORVASTATIN IN REDUCING PROTEINURIA IN PATIENTS OF CHRONIC KIDNEY DISEASE
title_full_unstemmed EFFICACY OF ATORVASTATIN IN REDUCING PROTEINURIA IN PATIENTS OF CHRONIC KIDNEY DISEASE
title_sort efficacy of atorvastatin in reducing proteinuria in patients of chronic kidney disease
publisher Army Medical College Rawalpindi
publishDate 2019
url https://doaj.org/article/e114ee44175f46adb5e160ccc7fb473d
work_keys_str_mv AT rizwanazam efficacyofatorvastatininreducingproteinuriainpatientsofchronickidneydisease
AT ejazahmed efficacyofatorvastatininreducingproteinuriainpatientsofchronickidneydisease
AT asadraza efficacyofatorvastatininreducingproteinuriainpatientsofchronickidneydisease
AT mahwishrizwan efficacyofatorvastatininreducingproteinuriainpatientsofchronickidneydisease
AT alijamal efficacyofatorvastatininreducingproteinuriainpatientsofchronickidneydisease
AT syedsalmanali efficacyofatorvastatininreducingproteinuriainpatientsofchronickidneydisease
_version_ 1718439639271866368